½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹NCF1(Ab-345)¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹NCF1(Ab-345)¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW20540
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º Íÿ¹NCF1(Ab-345) ¶à¿Ë¡¿¹Ìå


Ó¢ÎÄÃû³Æ£º Anti-NCF1(Ab-345) rabbit polyclonal antibody



±ð       Ãû£º NCF1A; NOXO2; p47phox; SH3PXD1A



Ïà¹ØÀà±ð£º Ò»¿¹


´¢      ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â


¿¹      Ô­£º NCF1(Ab-345)


ËÞ     Ö÷£º Rabbit


·´Ó¦ÖÖÊô£º Human


±ê  ¼Ç  Î Unconjugate


¿Ë¡ÀàÐÍ£º Unconjugate


¼¼Êõ¹æ¸ñ

Background:

NCF2, NCF1, and a membrane bound cytochrome b558 are required for activation of the latent NADPH oxidase (necessary for superoxide production).

Applications:

WB, IHC

Name of antibody:

NCF1(Ab-345)

Immunogen:

Synthesized non-phosphopeptide derived from human p47 phox around the phosphorylation site of serine 345 (P-Q-S(p)-P-G).

Full name:

neutrophil cytosolic factor 1

Synonyms£º

NCF1A; NOXO2; p47phox; SH3PXD1A

SwissProt:

P14598

IHC positive control:

Human brain tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

47 kDa

WB Positive control:

HepG2 cells treated with TNF (20ng/ml, 5mins) lysate

WB Recommended dilution:

500-3000






¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿